Live
ePaper
Search
Home > India > UPDATE 2-Lilly to buy Calytrix for up to $1.5 billion in rare blood cancer bet

UPDATE 2-Lilly to buy Calytrix for up to $1.5 billion in rare blood cancer bet

Written By:
Last Updated: November 16, 2026 20:46:50 IST

(Adds details and background throughout) Nov 16 (Reuters) – Eli Lilly has agreed to acquire privately held biotech Calytrix Bio for up to $1.5 billion in cash, as it looks to expand the development of

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?